Pages that link to "Q45732782"
Jump to navigation
Jump to search
The following pages link to Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection (Q45732782):
Displaying 50 items.
- Role of CD1d-restricted NKT cells in microbial immunity (Q24294851) (← links)
- The role of NKT cells in tumor immunity (Q24648939) (← links)
- Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agents (Q26748456) (← links)
- The Extended Family of CD1d-Restricted NKT Cells: Sifting through a Mixed Bag of TCRs, Antigens, and Functions (Q26797347) (← links)
- Fine tuning a well-oiled machine: Influence of NK1.1 and NKG2D on NKT cell development and function (Q26830239) (← links)
- Significant roles of regulatory T cells and myeloid derived suppressor cells in hepatitis B virus persistent infection and hepatitis B virus-related HCCs (Q28086980) (← links)
- Functional CD1d and/or NKT cell invariant chain transcript in horse, pig, African elephant and guinea pig, but not in ruminants (Q28754728) (← links)
- Immunology of hepatitis B virus and hepatitis C virus infection (Q29618957) (← links)
- Natural Killer T Cells Contribute to Neutrophil Recruitment and Ocular Tissue Damage in a Model of Intraocular Tumor Rejection (Q30375264) (← links)
- Incidence of hepatocellular carcinoma among individuals with hepatitis B virus infection identified using an automated data algorithm. (Q31140382) (← links)
- Non-classical natural killer T cells modulate plasmid DNA vaccine antigen expression and vaccine-elicited immune responses by MCP-1 secretion after interaction with a beta2-microglobulin-independent CD1d (Q33553298) (← links)
- Critical proinflammatory and anti-inflammatory functions of different subsets of CD1d-restricted natural killer T cells during Trypanosoma cruzi infection. (Q33558006) (← links)
- NKG2D modulates aggravation of liver inflammation by activating NK cells in HBV infection (Q33669781) (← links)
- Ex vivo analysis of resident hepatic pro-inflammatory CD1d-reactive T cells and hepatocyte surface CD1d expression in hepatitis C. (Q33744649) (← links)
- Regulation of CD1d expression and function by a herpesvirus infection (Q33768331) (← links)
- NKT-cell subsets: promoters and protectors in inflammatory liver disease (Q33862229) (← links)
- Novel model of antigen-specific induction of bile duct injury (Q33961567) (← links)
- Cytokine dependent and independent iNKT cell activation (Q34039891) (← links)
- Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. (Q34321127) (← links)
- Liver immunology (Q34359990) (← links)
- Invariant NKT cells: regulation and function during viral infection (Q34390484) (← links)
- Exacerbated susceptibility to infection-stimulated immunopathology in CD1d-deficient mice (Q34440132) (← links)
- IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B. (Q34627115) (← links)
- The unconventional lifestyle of NKT cells (Q34770393) (← links)
- Characteristics of circulating T cell receptor gamma-delta T cells from individuals chronically infected with hepatitis B virus (HBV): an association between V(delta)2 subtype and chronic HBV infection (Q34866687) (← links)
- Gamma Interferon Production by Hepatic NK T Cells during Escherichia coli Infection Is Resistant to the Inhibitory Effects of Oxidative Stress (Q34931790) (← links)
- Forming a complex with MHC class I molecules interferes with mouse CD1d functional expression (Q34979648) (← links)
- The CD1 family and T cell recognition of lipid antigens (Q35030902) (← links)
- Hepatic T cells and liver tolerance (Q35038298) (← links)
- Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammation (Q35103549) (← links)
- STING agonists induce an innate antiviral immune response against hepatitis B virus (Q35105855) (← links)
- Translation of immunological knowledge into better treatments of chronic hepatitis B. (Q35160324) (← links)
- The sterile inflammation in the exacerbation of HBV-associated liver injury (Q35373060) (← links)
- Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection (Q35568019) (← links)
- Immunopathogenesis of hepatitis B. (Q35621639) (← links)
- Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis (Q35783980) (← links)
- Genetic control of NKT cell numbers (Q35798141) (← links)
- NKT cells and viral immunity (Q35798179) (← links)
- Cell culture and animal models of viral hepatitis. Part I: hepatitis B. (Q35821246) (← links)
- Type II NKT cell-mediated anergy induction in type I NKT cells prevents inflammatory liver disease (Q35879532) (← links)
- Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA. (Q35914476) (← links)
- To be or not to be NKT: natural killer T cells in the liver. (Q35919440) (← links)
- Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus (Q36156880) (← links)
- Replication and gene expression of mutant hepatitis B virus in a transgenic mouse containing the complete viral genome with mutant s gene (Q36178105) (← links)
- Tumor necrosis factor-alpha blockage therapy impairs hepatitis B viral clearance and enhances T-cell exhaustion in a mouse model (Q36302689) (← links)
- Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity (Q36338265) (← links)
- V alpha14 i NKT cells are innate lymphocytes that participate in the immune response to diverse microbes (Q36354705) (← links)
- Immune system and hepatitis B virus infection (Q36388375) (← links)
- Animal models for the study of HBV replication and its variants (Q36388380) (← links)
- Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide (Q36399392) (← links)